{"id":7328,"date":"2026-03-30T13:34:31","date_gmt":"2026-03-30T17:34:31","guid":{"rendered":"https:\/\/cqdm.org\/?p=7328"},"modified":"2026-04-22T10:31:48","modified_gmt":"2026-04-22T14:31:48","slug":"call-for-ideas-ai-driven-multi-omics-integration-for-drug-discovery","status":"publish","type":"post","link":"https:\/\/cqdm.org\/en\/news-and-events\/call-for-ideas-ai-driven-multi-omics-integration-for-drug-discovery\/","title":{"rendered":"Call for Ideas: AI-Driven Multi-Omics Integration for Drug Discovery"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">CQDM is pleased to launch a call for ideas for the upcoming CQDM Connect-Pharma: Pitch Day, focused on AI-Driven Multi-Omics Integration for Drug Discovery. Selected applicants will present their innovations to experts from CQDM\u2019s global pharmaceutical members on May 28, 2026.<\/h4>\n\n\n\n<p>Our objective is to bring ground-breaking, innovative Canadian research to CQDM\u2019s pharmaceutical members and facilitate interactions between our pharma members and the Canadian ecosystem.<\/p>\n\n\n\n<p><strong>Pitch Day: <\/strong>May 28, 2026<br><strong>Submission Deadline: <\/strong>April 28, 2026<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Research Focus Areas include (but are not limited to):<\/strong><\/h3>\n\n\n\n<p>We are seeking innovative AI-enabled approaches that integrate multi-omics data\u2014genomics, transcriptomics, proteomics, metabolomics, epigenomics, spatial datasets, and clinical insights\u2014to advance target discovery, biomarker identification, and translational research.<\/p>\n\n\n\n<p><strong>AI-Enabled Target Identification &amp; Prioritization<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Integration of multi-omic datasets to uncover causal disease drivers<\/li>\n\n\n\n<li>Models bridging preclinical to human biology<\/li>\n\n\n\n<li>Cross-species translation algorithms<\/li>\n<\/ul>\n\n\n\n<p><strong>Multi-Omics Biomarker Discovery<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Patient stratification signatures<\/li>\n\n\n\n<li>Spatial and longitudinal biomarkers<\/li>\n\n\n\n<li>Predictive disease progression markers<\/li>\n<\/ul>\n\n\n\n<p><strong>Generative &amp; Predictive Models for Mechanistic Biology<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Foundation or LLM-based biological models<\/li>\n\n\n\n<li>Perturbation-response prediction (CRISPR, RNA-seq, proteomics)<\/li>\n\n\n\n<li>Pathway and network inference<\/li>\n<\/ul>\n\n\n\n<p><strong>Data Integration &amp; Harmonization Technologies<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fusion of heterogeneous datasets (omics, imaging, phenotypic)<\/li>\n\n\n\n<li>Normalization and batch-correction algorithms<\/li>\n\n\n\n<li>Interoperable multimodal data frameworks<\/li>\n<\/ul>\n\n\n\n<p><strong>Experimental\u2013Computational Hybrid Workflows<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Closed-loop AI-driven screening<\/li>\n\n\n\n<li>AI-guided CRISPR or functional genomics<\/li>\n\n\n\n<li>Active learning for experiment prioritization<\/li>\n<\/ul>\n\n\n\n<p><strong>Translational Applications<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Prediction of clinical outcomes<\/li>\n\n\n\n<li>Models linking molecular signatures to patient phenotypes<\/li>\n\n\n\n<li>Multi-omic precision medicine strategies<\/li>\n<\/ul>\n\n\n\n<p><strong>Therapeutic Areas of Interest<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Oncology<\/li>\n\n\n\n<li>Immunology &amp; Inflammation<\/li>\n\n\n\n<li>Rare Diseases<\/li>\n\n\n\n<li>Neuroscience<\/li>\n\n\n\n<li>Infectious Diseases<\/li>\n\n\n\n<li>Cardiometabolic Disorders<\/li>\n\n\n\n<li>Vaccines &amp; Immunization Science<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Process: <\/h3>\n\n\n\n<p>All submitted ideas will be evaluated by CQDM\u2019s pharmaceutical members. Top-ranked proposals will be selected to present at CQDM Connect-Pharma: Pitch Day on <strong>May 28, 2026.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Who can apply: <\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Canadian academic researchers and research hospitals<\/li>\n\n\n\n<li>Biotech companies and start-ups<\/li>\n\n\n\n<li>Cross-sector or interdisciplinary collaborations<\/li>\n\n\n\n<li>Academia\u2013industry partnerships<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-deep-blue-color has-grey-200-background-color has-text-color has-background has-link-color wp-elements-2bb0d1a4306f58a20391ac20fe8d1e77\">Submission Deadline: <strong>April 28, 2026<\/strong><br>Submit to: <a href=\"mailto:appliquez-apply@cqdm.org\">appliquez-apply@cqdm.org<\/a><br>For more information contact <a href=\"https:\/\/www.linkedin.com\/in\/simon-fournier-msc-mba-5977aa143\/\" target=\"_blank\" rel=\"noopener\">Simon Fournier<\/a>, <a href=\"mailto:sfournier@cqdm.org\">sfournier@cqdm.org<\/a>.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/cqdm.org\/wp-content\/uploads\/2026\/04\/Submission_Form_CQDM_AI_omics.docx\">Download the application form<\/a><\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\">About CQDM:<\/h3>\n\n\n\n<p><a href=\"https:\/\/cqdm.org\/en\/\">CQDM<\/a> is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&amp;D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CQDM is pleased to launch a call for ideas for the upcoming CQDM Connect-Pharma: Pitch Day, focused on AI-Driven Multi-Omics Integration for Drug Discovery. Selected applicants will present their innovations to experts from CQDM\u2019s global pharmaceutical members on May 28, 2026. Our objective is to bring ground-breaking, innovative Canadian research to CQDM\u2019s pharmaceutical members and&hellip;<\/p>\n","protected":false},"author":2,"featured_media":7657,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7328","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-our-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/comments?post=7328"}],"version-history":[{"count":7,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7328\/revisions"}],"predecessor-version":[{"id":7686,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7328\/revisions\/7686"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media\/7657"}],"wp:attachment":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media?parent=7328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/categories?post=7328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/tags?post=7328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}